Lux Capital Management

News, insights, analysis and data

← Back to Lux Capital Management profile

Lux Capital Management related stories

All articles and analysis

  • Venture-backed CTRL-labs buys Myo armband IP from North
    longmia@halifax.ca- 3 July 2019

    CTRL-labs has acquired the intellectual property for the Myo gestural armband from North, a Kitchener, Ontario-based wearable technology company. Terms weren't released for the deal, which CTRL-labs announced https://twitter.com/CTRLlabsCo?lang=en on Twitter. The New York-based neural interface technology developer said it will "bring these inventions back to life." North, which is said to have raised a US$40 million convertible debt financing https://www.pehub.com/canada/2019/05/north-secures-54-mln-in-bridge-financing-from-existing-vcs-gm/ earlier this year, recently focused on its augmented reality eyewear called Focals. In February, CTRL-labs reportedly https://www.geekwire.com/2019/amazons-alexa-fund-joins-28m-round-ctrl-labs-makers-neural-interface-technology/ closed a US$28 million round led by GV, Google’s venture capital arm, and joined by Amazon’s Alexa Fund, Lux Capital, Spark Capital and others.

  • Investors underwrite new era of chips
    Mark Boslet- 1 July 2019

    With Moore’s Law coming to an end, a new generation of semiconductor companies has seen a surge of investing. These task specific silicon makers could be the future, even if funding temporarily throttles back

  • Cala Health nabs $50 mln Series C
    Iris Dorbian- 21 May 2019

    Burlingame, California-based Cala Health, Inc, a bioelectronic medicine company, has raised $50 million in Series C financing. The investors included Novartis, Baird Capital, LifeSci Venture Partners, TriVentures, Johnson & Johnson Innovation – JJDC, Inc, Lux Capital, Lightstone Ventures, Action Potential Venture Capital, dRx Capital and GV.

  • Tempo Automation fetches $45 mln Series C
    Iris Dorbian- 14 May 2019

    San Francisco-based Tempo Automation, a manufacturer for prototyping and low-volume production of printed circuit board assemblies, has raised $45 million in Series C funding. Point72 Ventures led the round with participation from other backers that included Lockheed Martin, Lux Capital, Uncork Capital, Cendana and Golden Seeds.

  • CryptoNumerics raises $3.4 mln in 11.2 Capital-led seed round
    Kirk Falconer- 13 March 2019

    Toronto-based enterprise software company CryptoNumerics has raised about $3.4 million (US$2.5 million) in a seed-stage financing. The round was led by 11.2 Capital, a U.S. venture capital firm. It was joined by fellow U.S. investors Lux Capital and Silicon Valley Data Capital. Shelley Zhuang, an 11.2 Capital managing partner, will join the board. Founded last year and led by CEO Monica Holboke, CryptoNumerics helps organizations to use data to gain insights while overcoming privacy and data residency issues. Along with the round, CryptoNumerics announced the launch of its CN-Protect software, which uses artificial intelligence to create privacy-protected data sets.

  • CryptoNumerics gathers $2.5 mln seed
    Iris Dorbian- 13 March 2019

    Toronto-based CryptoNumerics, an enterprise software company, has raised $2.5 million in seed financing. The lead investor was 11.2 Capital. Lux Capital also participated in the round. In conjunction with the funding, Shelley Zhuang, a founder and managing partner at 11.2 Capital, has been added to CryptoNumerics' board of directors.

  • Zededa grabs $16 mln Series A
    Iris Dorbian- 25 February 2019

    Santa Clara, California-based Zededa, a provider of edge virtualization software, has secured $16 million in Series A funding. Energize Ventures and Lux Capital led the round.

  • Workit Health picks up Series A funding
    chris@arsenalvp.com- 31 January 2019

    Ann Arbor, Michigan and Lafayette, California-based Workit Health, a telehealth addiction treatment company, has raised an undisclosed amount of Series A funding. Blue Cross Blue Shield Venture Partners led the round with participation from other investors that included Endeavor Catalyst, Montage Ventures, Lux Capital, Wakestream Ventures, Invest Detroit and RRE Ventures.

  • Kallyope snags $21 mln
    Iris Dorbian- 5 December 2018

    New York City-based Kallyope Inc., a biotechnology company focused on identifying therapeutic opportunities involving the gut-brain axis, has secured $21 million in funding. The lead investor was Bill Gates. Other investors included Lux Capital, The Column Group, Polaris Partners, Illumina Ventures, Alexandria Venture Investments, Euclidean Capital and Two Sigma Ventures.